BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Gastrointestinal Oncology

The World Journal of Gastrointestinal Oncology (WJGO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of gastrointestinal oncology.  It was launched on October 15, 2009 and is published monthly (12 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage gastrointestinal oncologists worldwide to submit manuscripts to the WJGO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJGO are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJGO’s acceptance rate: 46%.  Submit here >>

2018 Published Issues
7 6 5 4 3 2 1
WJGO is now abstracted and indexed in PubMed, PubMed Central, Science Citation Index Expanded (SCIE, also known as SciSearch®), and Journal Citation Reports/Science Edition.
Journal Metrics
The 2018 edition of Journal Citation Reports® cites the 2017 impact factor for WJGO as 3.140 (5-year impact factor: 3.228), ranking WJGO as 39 among 80 journals in gastroenterology and hepatology (quartile in category Q2), and 114 among 222 journals in oncology (quartile in category Q3).
1948-5204 (online)
Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data 
Manish Chand, Deborah S Keller, Reza Mirnezami, Marc Bullock, Aneel Bhangu, Brendan Moran, Paris P Tekkis, Gina Brown, Alexander Mirnezami, Mariana Berho 
World J Gastrointest Oncol 10(7):145-158. Published online Jul 15, 2018. doi: 10.4251/wjgo.v10.i7.145
HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer 
Hazel Lote, Nicola Valeri, Ian Chau 
World J Gastrointest Oncol 10(7):159-171. Published online Jul 15, 2018. doi: 10.4251/wjgo.v10.i7.159
Advances in molecular, genetic and immune signatures of gastric cancer: Are we ready to apply them in our patients’ decision making? 
Stavros Gkolfinopoulos, Demetris Papamichael, Konstantinos Papadimitriou, Panos Papanastasopoulos, Vassilios Vassiliou, Panteleimon Kountourakis 
World J Gastrointest Oncol 10(7):172-183. Published online Jul 15, 2018. doi: 10.4251/wjgo.v10.i7.172
Prediction of malignancy and adverse outcome of solid pseudopapillary tumor of the pancreas 
Li You, Feng Yang, De-Liang Fu 
World J Gastrointest Oncol 10(7):184-193. Published online Jul 15, 2018. doi: 10.4251/wjgo.v10.i7.184
Retrospective Study
Atypical anastomotic malignancies of small bowel after subtotal gastrectomy with Billorth II gastroenterostomy for peptic ulcer: Report of three cases and review of the literature 
Efstathios Kotidis, Orestis Ioannidis, Manousos George Pramateftakis, Konstantinos Christou, Ioannis Kanellos, Konstantinos Tsalis 
World J Gastrointest Oncol 10(7):194-201. Published online Jul 15, 2018. doi: 10.4251/wjgo.v10.i7.194